Form 4 for DGX Quest Diagnostics
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001022079-24-000063 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-27 | 2024-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | F - Tax | $125.02 | -619 | 15.4K | -4% | -$77.4K | |
| 2024-02-27 | 2024-02-23 | DGX | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | A - Grant | $125.02 | +2,039 | 16.0K | +15% | +$254.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | F | D | 619 | $125.02 | 15,397 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-23 | A | A | 2,039 | $125.02 | 16,016 | D | — | — |